{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T17:23:18Z","timestamp":1764609798904,"version":"3.46.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.mrfmmm.2006.11.023","type":"journal-article","created":{"date-parts":[[2006,12,16]],"date-time":"2006-12-16T07:14:37Z","timestamp":1166253277000},"page":"70-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Differential cell cycle-specificity for chromosomal damage induced by merbarone and etoposide in V79 cells"],"prefix":"10.1016","volume":"616","author":[{"given":"Ling","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shambhu K.","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Eastmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrfmmm.2006.11.023_bib1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0309-1651(05)80016-5","article-title":"DNA topoisomerase II: a review of its involvement in chromosome structure, DNA replication, transcription and mitosis","volume":"16","author":"Anderson","year":"1992","journal-title":"Cell Biol. Int. Rep."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib2","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1016\/S0021-9258(20)89545-3","article-title":"DNA topoisomerases: why so many?","volume":"266","author":"Wang","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/(SICI)1098-1128(199707)17:4<367::AID-MED3>3.0.CO;2-U","article-title":"Recent advances in the discovery and development of topoisomerase inhibitors as antitumor agents","volume":"17","author":"Wang","year":"1997","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0167-4781(98)00133-X","article-title":"Catalytic inhibitors of DNA topoisomerase II","volume":"1400","author":"Andoh","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib5","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/0006-2952(88)90453-4","article-title":"Topoisomerases: novel therapeutic targets in cancer chemotherapy","volume":"37","author":"Hsiang","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1365-2710.2001.00368.x","article-title":"DNA topoisomerases as targets for anticancer drugs","volume":"26","author":"Topcu","year":"2001","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0163-7258(03)00058-5","article-title":"A catalytic topoisomerase II inhibitors in cancer therapy","volume":"99","author":"Larsen","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib8","first-page":"1509","article-title":"Differences in inhibition of chromosome separation and G2 arrest by DNA topoisomerase II inhibitors merbarone and VM-26","volume":"55","author":"Chen","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib9","first-page":"4074","article-title":"G2 arrest in response to topoisomerase II ihnibitors: the role of p53","volume":"63","author":"Clifford","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/372467a0","article-title":"A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells","volume":"372","author":"Downes","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib11","first-page":"2578","article-title":"In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone","volume":"49","author":"Drake","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib12","first-page":"1042","article-title":"Cell cycle progression and chromosome segregation in mammalian cells cultured in the presence of the topoisomerase II inhibitors ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane; ADR-529] andICRF-159 (Razoxane)","volume":"54","author":"Gorbsky","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib13","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0026-895X(24)12181-5","article-title":"Merbarone a catalytic inhibitor of DNA topoisomerase II, induces apoptosis in CEM cells through activation of ICE\/CED-3-like protease","volume":"55","author":"Khelifa","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1124\/mol.55.2.216","article-title":"DNA damage signals induction of fas ligand in tumor cells","volume":"55","author":"Mo","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0026-895X(24)23201-6","article-title":"Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)\/M checkpoint and apoptotic responses","volume":"57","author":"Morgan","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib16","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1006\/excr.1995.1107","article-title":"Inhibitors of topoisomerase II delay progress through mitosis and induce a doubling of the DNA content in CHO cells","volume":"217","author":"Sumner","year":"1995","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib17","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.molcel.2004.08.018","article-title":"Inhibition of DNA decatenation, but not DNA damage, arrests cells at metaphase","volume":"15","author":"Skoufias","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/em.10072","article-title":"Catalytic inhibitors of topoisomerase II are DNA-damaging agents: induction of chromosomal damage by merbarone and ICRF-187","volume":"39","author":"Wang","year":"2002","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1081\/DCT-120017554","article-title":"Evidence from studies with intact mammalian cells that merbarone and bis(dioxopiperazine)s are topoisomerase II poisons","volume":"26","author":"Snyder","year":"2003","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/em.10135","article-title":"Etoposide and merbarone are clastogenic and aneugenic in the mouse bone marrow micronucleus test complemented by fluorescence in situ hybridization with the mouse minor satellite DNA probe","volume":"41","author":"Attia","year":"2003","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib21","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1073\/pnas.84.20.7024","article-title":"Supercoiling of the DNA template during transcription","volume":"84","author":"Liu","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0092-8674(88)90163-8","article-title":"Transcription generates positively and negatively supercoiled domains in the template","volume":"53","author":"Wu","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0301-4622(88)87020-0","article-title":"DNA supercoiling in vivo","volume":"29","author":"Giaever","year":"1988","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1073\/pnas.231611798","article-title":"UV-induced replication arrest in the xeroderma pigmentosum variant leads to DNA double-strand breaks, gamma-H2AX formation, and Mre1 1 relocalization","volume":"99","author":"Limoli","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.onc.1202516","article-title":"Stark, p53 inhibits entry into mitosis when DNA synthesis is blocked","volume":"18","author":"Taylor","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0955-0674(02)00312-5","article-title":"A unified view of the DNA-damage checkpoint","volume":"14","author":"Melo","year":"2002","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib27","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1101\/gad.12.18.2956","article-title":"Recovery from DNA replicational stress is the essential function of the S-phase checkpoint pathway","volume":"12","author":"Desany","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib28","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0092-8674(88)90239-5","article-title":"The metaphase scaffold is helically folded: sister chromatids have predominantly opposite helical handedness","volume":"55","author":"Boy de la Tour","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib29","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1083\/jcb.111.6.2839","article-title":"Mitotic chromatin condensation in vitro using somatic cell extracts and nuclei with variable levels of endogenous topoisomerase II","volume":"111","author":"Wood","year":"1990","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0092-8674(91)90215-K","article-title":"Chromosome assembly in vitro: topoisomerase II is required for condensation","volume":"64","author":"Adachi","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib31","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/sj.embor.7400465","article-title":"Topoisomerase II\u2013DNA complexes trapped by ICRF-193 perturb chromatin structure","volume":"6","author":"Germe","year":"2005","journal-title":"EMBO Rep."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib32","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1083\/jcb.117.5.921","article-title":"Sister chromatid separation in frog egg extracts requires DNA topoisomerase II activity during anaphase","volume":"117","author":"Shamu","year":"1992","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000134517","article-title":"Topoisomerase II inhibition in mitosis produces numerical and structural chromosomal aberrations in human fibroblasts","volume":"76","author":"Cimini","year":"1997","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/mutage\/11.5.435","article-title":"Fragmentation of centromeric DNA and prevention of homologous chromosome separation in male mouse meiosis in vivo by the topoisomerase II inhibitor etoposide","volume":"11","author":"Kallio","year":"1996","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/35096590","article-title":"DNA topoisomerase IIalpha is required for RNA polymerase II transcription on chromatin templates","volume":"413","author":"Mondal","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib36","doi-asserted-by":"crossref","first-page":"8437","DOI":"10.1128\/MCB.21.24.8437-8451.2001","article-title":"Transcriptional consequences of topoisomerase inhibition","volume":"21","author":"Collins","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/jmg.13.2.103","article-title":"Classification and relationships of induced chromosomal structural changes","volume":"13","author":"Savage","year":"1976","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/B:SCAM.0000007135.12486.e3","article-title":"Phosphatase inhibitors and premature chromosome condensation in human peripheral lymphocytes at different cell-cycle phases","volume":"25","author":"Kanda","year":"1999","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0091-679X(08)61582-4","article-title":"Cell synchronization","volume":"57","author":"Merrill","year":"1998","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib40","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0014-4827(84)90647-5","article-title":"Kinetics of G1 transit following brief starvation for serum factors","volume":"152","author":"Campisi","year":"1984","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0091-679X(08)60447-1","article-title":"Repetitive synchronization of human lymphoblast cultures with excess thymidine","volume":"8","author":"Zielke","year":"1974","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0378-4274(96)03724-1","article-title":"A rapid method for detection of nongenotoxic carcinogens of environmental pollutants using synchronized V79 cells and flow cytometry","volume":"88","author":"Hader","year":"1996","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib43","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0955-0674(00)00280-5","article-title":"S-phase checkpoints in response to DNA damage","volume":"13","author":"Bartek","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00230954","article-title":"The molecular basis of drug-induced G2 arrest in mammalian cells","volume":"29","author":"Rao","year":"1980","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib45","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0092-8674(85)80028-3","article-title":"DNA topoisomerase II is required at the time of mitosis in yeast","volume":"41","author":"Holm","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib46","first-page":"159","article-title":"DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage","volume":"9","author":"Holm","year":"1989","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib47","doi-asserted-by":"crossref","first-page":"8895","DOI":"10.1073\/pnas.88.20.8895","article-title":"Inhibitors of DNA topoisomerase II prevent chromatid separation in mammalian cells but do not prevent exit from mitosis","volume":"88","author":"Downes","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib48","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1242\/jcs.105.2.563","article-title":"Topoisomerase II inhibition prevents anaphase chromatid segregation in mammalian cells independently of the generation of DNA strand breaks","volume":"105","author":"Clarke","year":"1993","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1242\/jcs.103.1.105","article-title":"Inhibitors of topoisomerases do not block the passage of human lymphocyte chromosomes through mitosis","volume":"103","author":"Sumner","year":"1992","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0378-4274(00)00192-2","article-title":"Genotoxicity of several clinically used topoisomerase II inhibitors","volume":"116","author":"Boos","year":"2000","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib51","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1172\/JCI25716","article-title":"Early G2\/M checkpoint failure as a molecular mechanism underlying etoposide-induced chromosomal aberrations","volume":"116","author":"Nakada","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib52","first-page":"3761","article-title":"Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells","volume":"50","author":"Lock","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib53","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1083\/jcb.111.5.1753","article-title":"The topoisomerase II inhibitor VM-26 induces marked changes in histone H1 kinase activity, histones H1 and H3 phosphorylation, and chromosome condensation in G2 phase and mitotic BHK cells","volume":"111","author":"Roberge","year":"1990","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib54","first-page":"134","article-title":"Nuclear matrix targets for anticancer agents","volume":"3","author":"Fernandes","year":"1991","journal-title":"Cancer Cells"},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib55","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1021\/bi963101b","article-title":"Arrest of replication fork progression at sites of topoisomerase II-mediated DNA cleavage in human leukemia CEM cells incubated with VM-26","volume":"36","author":"Catapano","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib56","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0027-5107(98)00041-4","article-title":"DNA signals for G2 checkpoint response in diploid human fibroblasts","volume":"400","author":"Kaufmann","year":"1998","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib57","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1128\/jvi.64.2.691-699.1990","article-title":"Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome","volume":"64","author":"Wong","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib58","first-page":"2774","article-title":"Developmental regulation of topoisomerase II sites and DNase I-hypersensitive sites in the chicken beta-globin locus","volume":"10","author":"Reitman","year":"1990","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib59","first-page":"861","article-title":"Differences in induction of p53, p21WAF1 and apoptosis in relation to cell cycle phase of MCF-7 cells treated with camptothecin","volume":"15","author":"Deptala","year":"1999","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib60","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0027-5107(81)90021-X","article-title":"The induction of chromosome-type aberrations in G1 by methyl methanesulfonate and 4-nitroquinoline-N-oxide, and the non-requirement of an S-phase for their production","volume":"83","author":"Preston","year":"1981","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib61","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0027-5107(87)90257-0","article-title":"Effects of repair inhibition in the G1 phase of clastogen-treated human lymphocytes on the frequencies of chromosome-type and chromatid-type aberrations and sister-chromatid exchanges","volume":"176","author":"Kishi","year":"1987","journal-title":"Mutat. Res."},{"issue":"Suppl. (104)","key":"10.1016\/j.mrfmmm.2006.11.023_bib62","first-page":"1319","article-title":"Inhibition of human topoisomerase II in vitro by bioactive benzene metabolites","volume":"6","author":"Frantz","year":"1996","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1081\/DCT-100100099","article-title":"Recent developments in the understanding of benzene toxicity and leukemogenesis","volume":"23","author":"Snyder","year":"2000","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib64","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/np50116a009","article-title":"Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships","volume":"58","author":"Constantinou","year":"1995","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib65","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mrgentox.2005.01.002","article-title":"Chromosomal malsegregation and micronucleus induction in vitro by the DNA topoisomerase II inhibitor fisetin","volume":"582","author":"Olaharski","year":"2005","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib66","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/mutage\/10.4.343","article-title":"Genotoxicity of 17 gyrase- and four mammalian topoisomerase II-poisons in prokaryotic and eukaryotic test systems","volume":"10","author":"Albertini","year":"1995","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib67","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1098-2280(1997)29:1<16::AID-EM3>3.0.CO;2-B","article-title":"Effects of the DNA topoisomerase II inhibitor merbarone in male mouse meiotic divisions in vivo: cell cycle arrest and induction of aneuploidy","volume":"29","author":"Kallio","year":"1997","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib68","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0165-1218(93)90081-N","article-title":"Micronuclei in neonatal lymphocytes treated with the topoisomerase II inhibitors amsacrine and etoposide","volume":"319","author":"Slavotinek","year":"1993","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrfmmm.2006.11.023_bib69","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/em.2850240308","article-title":"Etoposide (VP-16) is a potent inducer of micronuclei in male rat meiosis: spermatid micronucleus test and DNA flow cytometry after etoposide treatment","volume":"24","author":"Lahdetie","year":"1994","journal-title":"Environ. Mol. Mutagen."}],"container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510706003356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510706003356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T17:18:28Z","timestamp":1764609508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027510706003356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":69,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0027510706003356"],"URL":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2006.11.023","relation":{},"ISSN":["1386-1964"],"issn-type":[{"type":"print","value":"1386-1964"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential cell cycle-specificity for chromosomal damage induced by merbarone and etoposide in V79 cells","name":"articletitle","label":"Article Title"},{"value":"Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2006.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}